Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
A computer simulation model for cost-effectiveness analysis of mass screening for Type 2 diabetes mellitus
Autore:
Chen, THH; Yen, MF; Tung, TH;
Indirizzi:
Natl Taiwan Univ, Coll Publ Hlth, Grad Inst Epidemiol, Taipei 10764, Taiwan Natl Taiwan Univ Taipei Taiwan 10764 nst Epidemiol, Taipei 10764, Taiwan Natl Yang Ming Univ, Community Med Res Ctr, Taipei 112, Taiwan Natl Yang Ming Univ Taipei Taiwan 112 ty Med Res Ctr, Taipei 112, Taiwan Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan Natl Yang Ming Univ Taipei Taiwan 112 Inst Publ Hlth, Taipei 112, Taiwan
Titolo Testata:
DIABETES RESEARCH AND CLINICAL PRACTICE
, volume: 54, anno: 2001, supplemento:, 1
pagine: S37 - S42
SICI:
0168-8227(200111)54:<S37:ACSMFC>2.0.ZU;2-Y
Fonte:
ISI
Lingua:
ENG
Soggetto:
PREVALENCE; ROCHESTER; NIDDM; COMPLICATIONS; RETINOPATHY; AMPUTATION; MINNESOTA; COMMUNITY; ONSET;
Keywords:
cost-effectiveness analysis; Type 2 diabetes mellitus; mass screening; Markov model; Monte Carol computer simulation;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Citazioni:
25
Recensione:
Indirizzi per estratti:
Indirizzo: Chen, THH Natl Taiwan Univ, Coll Publ Hlth, Grad Inst Epidemiol, Taipei 10764, Taiwan Natl Taiwan Univ Taipei Taiwan 10764 iol, Taipei 10764, Taiwan
Citazione:
T.H.H. Chen et al., "A computer simulation model for cost-effectiveness analysis of mass screening for Type 2 diabetes mellitus", DIABET RE C, 54, 2001, pp. S37-S42

Abstract

The cost-effectiveness analysis of mass screening for Type 2 diabetes mellitus (DM) was performed to elucidate whether, who and how often it should be conducted in Taiwan. A series of Markov process was developed to model the disease natural history of Type 2 DM. A hypothetical cohort with 30 000 residents aged over 30 years in Taiwan was randomly assigned to three arms of screening regimes, biennial, five-yearly and the control group. A Monteo Carol computer simulation was performed to calculate effectiveness of two screening regimes compared with the control group. Direct costs and utilities were incorporated to each corresponding state to calculate the incremental costs per life-years gained and per quality-adjusted life-years (QALYs) for biennial and five-yearly screening regimes. The incremental costs for biennial screening regime were estimated at $26 750 per life-year gained, and$17 833 per QALY. The corresponding figures for five-yearly screening regime were $10 531 per Life-year gained and $17 113 per QALY. The incremental costs per life-year gained and per QALY increase with age, ranging from $17238 for aged 30-39 years to $54 700 for aged over 70 years and from $9193 to 36 467, respectively. In conclusion, mass screening for Type 2 DM. especially in younger subjects, with 5-year inter-screening interval is cost-effective in Taiwan. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 26/01/21 alle ore 03:21:19